AMA Medical Manufacturing Limited
Nigerian pharmaceutical manufacturer
AMA Medical Manufacturing Limited (trading as AMA-MED) is a Nigerian pharmaceutical company that produces intravenous (IV) fluid solutions at a facility in the Kudenda Industrial Layout in Kaduna, Kaduna State. Founded in 2019, the company is listed by the National Agency for Food and Drug Administration and Control (NAFDAC) among registered pharmaceutical manufacturers in Nigeria's North West Zone. It is a subsidiary of AMA Investment & Infrastructure Holdings.
History
AMA Medical Manufacturing was incorporated in 2019 under Systems Trade & Services Nigeria Limited. Construction of its first manufacturing facility in Kaduna began shortly afterwards.
On 14 March 2024, World Trade Organization Director-General Ngozi Okonjo-Iweala performed the groundbreaking ceremony for the second phase of the company's plant. The event was attended by Ali Muhammad Pate, Nigeria's Coordinating Minister of Health and Social Welfare, and a representative of Vice President Kashim Shettima. Okonjo-Iweala described the project as relevant to regional trade and pharmaceutical supply across Africa.
In August 2024, AMA Medical signed a memorandum of understanding with Echitab Study Group Nigeria and the United Kingdom-based firm Micropharm Ltd for the local production of anti-snake venom drugs in Nigeria. The agreement was signed at the company's Kudenda facility and was described by reporting outlets as a step toward domestic production of anti-snake venom, which had historically been manufactured in the United Kingdom and Costa Rica.
Begin with the source’s own compact description: “AMA Medical Manufacturing Limited” is nigerian pharmaceutical manufacturer. The dossier treats that line as a proposition to test through Medical, Manufacturing and Limited, not as a finished interpretation.
Why this record matters
The phrase “nigerian pharmaceutical manufacturer” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Sep 23, 2026. The linked authority identifier is Q141253817. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2019 and 2024.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “AMA Medical Manufacturing Limited”, its source revision and the description used here.
- Expand the search: follow AMA Medical Manufacturing Limited primary sources, AMA Medical Manufacturing Limited archive and Medical research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “AMA Medical Manufacturing Limited”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “AMA Medical Manufacturing Limited” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.